Asset Allocation

As of August 31, 2025.
Type % Net
Cash 4.46%
Stock 65.85%
Bond 29.03%
Convertible 0.00%
Preferred 0.00%
Other 0.67%
View Asset Allocation
Start Trial

Market Capitalization

As of August 31, 2025
Large 86.20%
Mid 10.58%
Small 3.22%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.19%    % Emerging Markets: 0.07%    % Unidentified Markets: 0.74%

Americas 80.42%
79.94%
Canada 41.11%
United States 38.83%
0.48%
As of August 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 17.21%
United Kingdom 4.75%
11.33%
Belgium 1.17%
France 1.98%
Germany 3.39%
Ireland 1.90%
Italy 0.00%
Netherlands 1.42%
Switzerland 1.46%
0.00%
1.13%
Israel 1.08%
United Arab Emirates 0.05%
Greater Asia 1.63%
Japan 1.63%
0.00%
Australia 0.00%
0.00%
0.00%
Unidentified Region 0.74%

Bond Credit Quality Exposure

AAA 14.46%
AA 10.36%
A 18.96%
BBB 28.98%
BB 12.18%
B 7.27%
Below B 0.43%
    CCC 0.43%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.17%
Not Available 6.19%
Short Term 0.00%
As of August 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.54%
Materials
3.05%
Consumer Discretionary
4.69%
Financials
14.96%
Real Estate
2.84%
Sensitive
28.53%
Communication Services
3.30%
Energy
2.74%
Industrials
9.77%
Information Technology
12.72%
Defensive
13.07%
Consumer Staples
6.35%
Health Care
5.16%
Utilities
1.55%
Not Classified
32.86%
Non Classified Equity
0.43%
Not Classified - Non Equity
32.42%
As of August 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of August 31, 2025
Type % Net
Government 10.85%
Corporate 67.11%
Securitized 0.36%
Municipal 13.29%
Other 8.39%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.46%
Less than 1 Year
0.46%
Intermediate
68.90%
1 to 3 Years
9.08%
3 to 5 Years
20.00%
5 to 10 Years
39.82%
Long Term
28.61%
10 to 20 Years
5.04%
20 to 30 Years
12.30%
Over 30 Years
11.27%
Other
2.04%
As of August 31, 2025
View Bond Maturity Exposure
Start Trial